ArielEFeldsteinMD

Professor, Pediatrics, University of California San Diego School of Medic

Dr. Feldstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
8110 Birmingham Way
Bldg 28
San Diego, CA 92123
Phone+1 858-966-4003

Fax+1 858-560-6798

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pediatric Gastroenterology, 2001 - 2004
Mayo Clinic College of Medicine and Science (Rochester)Residency, Pediatrics, 1998 - 2001
University of Buenos AiresClass of 1997

PubMed

275 citations
High‐fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis
Rohit Kohli, Michelle Kirby, Stavra A. Xanthakos, Samir Softic, Ariel E. Feldstein
Hepatology. 2010-09-01
3648 citations
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang, Elizabeth Klipfell, Brian J. Bennett, Robert A. Koeth, Bruce S. Levison
Nature. 2011-04-07
530 citations
The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
Ariel E. Feldstein, Phunchai Charatcharoenwitthaya, Sombat Treeprasertsuk, Joanne T. Benson, Felicity B. Enders
Gut. 2009-11-01

Journal Articles

Non‐Alcoholic Fatty Liver Disease in Pediatric Type 2 Diabetes: Metabolic and Histologic Characteristics in 38 Subjects
Ron S Newfield, Ariel E Feldstein, Jeffrey B Schwimmer, Robert O Newbury, Daphne S Say, Pediatric Diabetes
Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis
Rohit Loomba, Ariel E Feldstein, The Journal of Immunology
Fatty Liver in Adolescents: Mechanisms, Clinical Features and Therapy
Ariel Feldstein, MD, Journal of Hepatology

Genentech Acquires Jecure TherapeuticsNovember 27th, 2018
Young, Fat and Facing Liver Disease: As Obesity Rates Climb, Fatty Livers Are Emerging as a Serious Threat to Children’s HealthMay 16th, 2018
Versant Ventures Launches Jecure TherapeuticsDecember 14th, 2017
Join now to see all

Exploratory Project: 1 Mitochondrial Phospholipid Oxidation In Alcoholic LiverNational Institute On Alcohol Abuse And Alcoholism2009–2011
Caspase Dependent Cell Death In Nonalcoholic Fatty Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
The Lysosomal-Mitochondrial Axis In Nonalcoholic Fatty Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011